Resources
Resources
Strengthening Supply Chain and Pharmaceutical Systems for Sustained Health Impact
For more than three decades, Management Sciences for Health (MSH) has partnered with countries to build high-performing supply chains that ensure reliable access to safe, effective, quality-assured medicines and people-centered pharmaceutical services. MSH takes a holistic approach that fosters country-led innovation, whole-of-society engagement and collaboration, private-sector engagement, and effective leadership and governance. This ensures both reliable, affordable access to and sustainable delivery of medical products when and where they are needed and their appropriate use to save lives and improve health.
Topical
Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity – January 2026 Monthly Newsletter and Technical Brief
Newsletter In this issue, you’ll find the following stories: Technical Brief – Ukraine’s Medical Procurement Landscape: The Journey to Saf…
Antimicrobial Resistance (AMR) Alert: Quarterly Bulletin Series
Generating Environmental Health AMR Data
Key Considerations and Strategies for Strengthening COVID-19 Diagnostics Supply Chains in Low- and Middle-Income Country Settings
COVID-19 Diagnosis in Low- and Middle-income Countries: The Big New Bully Disrupting TB and HIV Diagnostic Services
Abstract COVID-19 undermines control of other infectious diseases. Diagnostics are critical in health care. This opinion paper explores approaches for…
Facilitating COVID-19 Vaccine Introduction and Distribution in Low- and Middle-income Countries
A Landscape Analysis of Laboratory Technologies for COVID-19 Response in Low- and Middle-Income Countries
COVID-19 Vaccines Pricing Policy Options for Low-Income and Middle-Income Countries
Summary The COVID-19 pandemic limits pricing policy options for vaccines. It is therefore necessary to consider what appropriate policy options govern…
Willingness to Comply with Physical Distancing Measures against COVID-19 in Four African Countries
The world is facing an unprecedented crisis related to the COVID-19 pandemic with many unknowns, which has led to much confusion and anxiety. …
Key Achievements and Lessons Learned from the Pilot TB/COVID-19 Integration Model from the ACT-A Project in Ethiopia
MSH, with funding from FIND, the global alliance for diagnostics, through the Access to COVID-19 Tools Accelerator (ACT-A), implemented the COVID-19 A…
Evolution of the COVID-19 pandemic over six weeks in four French-speaking countries in West Africa
The novel Coronavirus disease 2019 (COVID-19; caused by the virus SARS-CoV-2) is severely challenging health systems worldwide. In Africa, the first c…
Sharing Knowledge for Policy Action in Low- and Middle-income Countries: A Literature Review of Managed Entry Agreements
Managed entry agreements (MEAs)—a type of formal institutional arrangement between pharmaceutical companies and payers for sharing the risk with re…
Annual Report 2020: Locally Leading the Way to Fight COVID-19
COVID-19 Vaccination Integration, Innovations and Key Populations: Results from a Global Survey
COVID-19 vaccine integration into routine health care is shifting from mass campaigns to regular services in LMICs, but resource-intensive methods rem…
